CClinicalTrials.gg
CompletedNCT03207607Updated Jul 5, 2017

Mid-morning Gel Snacks on Subjective Appetite, Glycemic and Insulin Responses, and Food Intake

An interventional study of Control snack and Maltodextrin snack in Satiety and Food Intake, sponsored by Toronto Metropolitan University. Completed at 1 site in Canada. Open to participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-07-05.

Sponsored by Toronto Metropolitan University · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 1 year 4 months after the study started (first participant enrolled Feb 2016, registered Jun 2017).
Phase
Not applicable
Study type
Interventional
Enrollment
23
Allocation
Randomized
Ages
18 Years to 30 Years
Sex
All
01

Study summary

The purpose of this study was to determine the effect of mid-morning gel snacks on subjective appetite, glucose and insulin responses, and food intake in healthy weight young adults.

Read the detailed description

23 (14 male, 9 female) healthy, non-smoking human subjects aged 18-30 years with a body mass index (BMI) between 20 and 24.9 were recruited in the experiment. Five gel snacks including a control snack and four modified snacks containing whey protein, oats, coconut oil or maltodextrin were tested. On six separate mornings, at least 3 days apart and after a 12 hours overnight fast, each participant consumed a standardized breakfast of cereal, milk, and orange juice at home, then arrived in the lab 2 hours after breakfast to receive one of the five test snack treatments or skip snack. Subjective appetite by a 100 mm visual analogue scale (VAS) was measured at baseline (0 min) and after each treatment up to 2 h (15, 30, 60, 90, and 120 min). Blood glucose and insulin concentrations were measured via finger-prick at the same time VAS measurements were taken. Food intake was measured via ad libitum pizza lunch.

02

Conditions studied

  • Satiety
  • Food Intake

Keywords

  • Adults
  • Snacks
  • Appetite
  • Blood glucose
  • Insulin
03

In context

Lead sponsor

Toronto Metropolitan University is the lead sponsor of 62 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • be between 18 and 30 years of age
  • be healthy, non-smoking and not be taking any medications, including birth control
  • body mass index (BMI) between 20 and 24.9

Exclusion criteria

Exclusion Criteria:

  • fasting plasma glucose >5.5 mmol/L
  • health problems including previously diagnosed diabetes, known or uncertain pregnancy status at screening, gastrointestinal disease, liver or kidney disease
  • major medical or surgical event within the past 6 months
  • current or recent dieting
  • breakfast skipping
  • receiving any medications
  • menstrual irregularities
  • food sensitivities, allergies, intolerances, or dietary restrictions to foods including: cereal, orange juice, dairy, oat, coconut oil, honey, apple, pineapple, strawberry, and pear
  • behavioural or emotional problems
  • alcohol consumption >7 beverages/week
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
23 participants (actual)

Study arms

  • Experimental
    Control snack

    Participants received control snacks prepared by real fruits (pear, orange and mango)

    Other: Control snack

  • Experimental
    Maltodextrin snack

    Participants received maltodextrin snacks (maltodextrin + control snack)

    Other: Maltodextrin snack

  • Experimental
    Whey protein snack

    Participants received whey protein snacks (whey protein + control snack)

    Other: Whey protein snack

  • Experimental
    Oat snack

    Participants received oat snacks (oat + maltodextrin + control snack)

    Other: Oat snack

  • Experimental
    Coconut oil snack

    Participants received coconut oil snacks (coconut oil + control snack)

    Other: Coconut oil snack

  • Experimental
    Snack skipping

    Participants received snack skipping

    Other: Snack skipping

Interventions

  • OtherControl snack

    Isovolumetric (238.4g) gel snack prepared by real fruits (186.2kcal)

  • OtherMaltodextrin snack

    Isovolumetric (238.4g) gel snack with maltodextrin (271.8kcal)

  • OtherWhey protein snack

    Isovolumetric (238.4g) gel snack with whey protein (201.8kcal)

  • OtherOat snack

    Isovolumetric (238.4g) gel snack with oats and maltodextrin (275.8kcal)

  • OtherCoconut oil snack

    Isovolumetric (238.4g) gel snack with coconut oil (276.4kcal)

  • OtherSnack skipping

    no snack

06

What researchers measure

Primary outcomes

  1. Subjective Appetite

    Participants completed subjective ratings on appetite (e.g., desire to eat, hunger, fullness, prospective food consumption) and well-being at baseline (0 min), 15, 30, 45, 60, 90, and 120 min after snack consumption, as well as immediately following lunch.

    Time frame: Change from baseline over 120 minutes

Secondary outcomes

  1. Blood Glucose Response

    Blood was collected at baseline (0min), 15, 30, 45, 60, 90, and 120 min after snack consumption, as well as immediately following lunch to observe glycemic responses to gel snacks

    Time frame: Change from baseline over 120 minutes

  2. Blood Insulin Response

    Blood was collected at baseline (0 min), 15, 30, 45, 60, 90, and 120 min after meal consumption, as well as immediately following lunch, to observe insulin responses to gel snacks

    Time frame: Change from baseline over 120 minutes

  3. Food Intake

    Participants consumed an ad libitum pizza lunch at 120 minutes

    Time frame: 30 min

07

Study locations

1 site
  • School of Nutrition, Ryerson University
    Toronto, Ontario M5B 2K3, Canada
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 5, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03207607
Lead sponsor
Toronto Metropolitan University
Collaborators
The Hershey Company
Responsible party
Nick Bellissimo (PhD, Toronto Metropolitan University) — Principal investigator
First posted
Jul 5, 2017
Start date
Feb 2016
Primary completion
Aug 2016
Completion
Aug 2016
Last update
Jul 5, 2017

Study contacts

Nick Bellissimo, PhD
principal investigator · Toronto Metropolitan University
Derick Rousseau, PhD
principal investigator · Toronto Metropolitan University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion